Breckenridge launches Pomalidomide Capsules, strengthening its oncology portfolio
BERKELEY HEIGHTS, N.J., March 2, 2026 /PRNewswire/ — Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced the launch of Pomalidomide Capsules, a generic version of Pomalyst® by Celgene (now Bristol Myers Squibb), within the oncology therapeutic category. The product was developed in collaboration with NATCO Pharma Limited of […]
